A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG

NCT00402506 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Bypass Graft Surgery
Myocardial Ischemia
Reperfusion Injury

Interventions

DRUG: (MC-1) Pyridoxal 5'-phosphate

Sponsor

Medicure